vimarsana.com

Page 2 - இருக்கலாம் இரு பயன்படுத்தப்பட்டது News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Study Investigates the Ability of Masimo PVi® to Predict Preload Responsiveness in Patients On Nasal High-Flow Therapy

Share: Masimo (NASDAQ:MASI) announced today the findings of a study published in the Journal of Applied Physiology in which Dr. Marina García-de-Acilu and colleagues at the Vall d Hebron University Hospital in Barcelona evaluated the utility of Masimo PVi ® as a noninvasive method of predicting preload responsiveness in patients treated with nasal high-flow (NHF) therapy. They found that PVi may identify preload responders and noted that PVi may therefore be used in the day-to-day clinical decision-making process in critically ill patients treated with NHF, helping to provide adequate resuscitation volume. 1 More than 100 independent studies have demonstrated the utility of PVi as an indicator of fluid responsiveness.

HHS OIG Targets Ophthalmology Practices for Medicare Billing Compliance: Eight Key Takeaways | McGuireWoods LLP

To embed, copy and paste the code into your website or blog: One of the most challenging billing compliance issues ophthalmology practices encounter in coding and reimbursement is understanding when services provided on the same day as a surgical procedure are payable separately from Medicare’s “global surgery payment.” On March 29, 2021, the U.S. Department of Health and Human Services’ (HHS’) Office of Inspector General (OIG) released a report, An Ophthalmology Clinic in California: Audit of Medicare Payments for Eye Injections of Eylea and Lucentis, examining these issues in an audit of an ophthalmology practice’s billing of Medicare for intravitreal injections and other services provided to patients on the same day as the injections. The clinic was not specifically identified by the OIG, but is located in Newport Beach, California, and opened in 2008.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.